Literature DB >> 18449464

High frequency of p16 promoter methylation in non-small cell lung carcinomas from Chile.

Leda M Guzman1, Chihaya Koriyama, Suminori Akiba, Yoshito Eizuru, Darwins Castillo, Alejandro Corvalan, Francisco R Aguayo.   

Abstract

The inactivation of tumour suppressor genes by aberrant methylation of promoter regions has been described as a frequent event in neoplasia development, including lung cancer. The p16 gene is a tumour suppressor gene involved in the regulation of cell cycle progression that has been reported to be inactivated by promoter methylation in lung carcinomas at variable frequencies around the world in a smoking habit dependent manner. The purpose of this study was to investigate the methylation status of the promoter region of the p16 gene in 74 non-small cell lung carcinomas from Chile. The frequency of p16 gene inactivation by promoter methylation was determined as 79.7% (59/74). When we considered histological type, we observed that p16 promoter methylation was significantly higher in squamous cell carcinomas (30/33, 91%) compared with adenocarcinomas (21/30, 70%) (p=0.029). In addition, no association between p16 promoter methylation and gender, age or smoking habit was found (p=0.202, 0.202 and 0.147 respectively). Our results suggest that p16 promoter hypermethylation is a very frequent event in non-small cell lung carcinomas from Chile and could be smoking habit-independent.

Entities:  

Mesh:

Year:  2008        PMID: 18449464     DOI: /S0716-97602007000400011

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  6 in total

1.  DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract.

Authors:  Samson Mani; Katarzyna Szymańska; Cyrille Cuenin; David Zaridze; Karen Balassiano; Sheila C S Lima; Elena Matos; Alexander Daudt; Sergio Koifman; Victor Wunsch Filho; Ana M B Menezes; Maria Paula Curado; Gilles Ferro; Thomas Vaissière; Bakary S Sylla; Massimo Tommasino; Luis Felipe Ribeiro Pinto; Paolo Boffetta; Pierre Hainaut; Paul Brennan; Zdenko Herceg
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

2.  Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.

Authors:  Leda Guzmán; María Soledad Depix; Ana María Salinas; Rosa Roldán; Francisco Aguayo; Alejandra Silva; Raul Vinet
Journal:  Diagn Pathol       Date:  2012-07-20       Impact factor: 2.644

3.  Smoking and prognostic factors in an observational setting in patients with advanced non-small cell lung carcinoma.

Authors:  Chien-Te Li; Magdalena Marek; Salih Z Guclu; Younseup Kim; Mohamed Meshref; Shukui Qin; Zbigniew Kadziola; Kurt Krejcy; Sedat Altug
Journal:  J Cancer       Date:  2011-01-11       Impact factor: 4.207

4.  Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.

Authors:  Bo Zhang; Wei Zhu; Ping Yang; Tao Liu; Mei Jiang; Zhi-Ni He; Shi-Xin Zhang; Wei-Qing Chen; Wen Chen
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

Review 5.  [Advances of DNA methylation in early diagnosis of lung cancer].

Authors:  Xiaoming Qiu; Yanjie Qiao; Bin Liu; Yang Li; Jiacong You; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-04

6.  Prevalence of p16 methylation and prognostic factors in plasma cell myeloma at a single institution in Korea.

Authors:  Hyunjung Kim; Dong Wook Jekarl; Myungshin Kim; Yonggoo Kim; Jihyang Lim; Kyungja Han; Chang-Ki Min
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.